Resolution of hydrops fetalis in congenital cystic adenomatoid malformation after prenatal steroid therapy

KuoJen Tsao, Samuel Hawgood, Lan Vu, Shinjiro Hirose, Roman Sydorak, Craig T. Albanese, Diana L Farmer, Michael R. Harrison, Hanmin Lee

Research output: Contribution to journalArticle

111 Citations (Scopus)

Abstract

Background/Purpose: Development of hydrops fetalis in fetuses with congenital cystic adenomatoid malformations (CCAM) is a significant risk factor for fetal or neonatal demise. In rare cases, resolution of CCAM has occurred, presumably owing to lesion maturation or involution. Steroid therapy, utilized for lung maturity, has been postulated to accelerate this process. The natural history of hydropic fetuses with CCAM after receiving steroid therapy is presented. Methods: The authors prospectively followed up with 3 patients who had antenatally diagnosed CCAM and nonimmune hydrops fetalis with predicted mortality. All patients declined or were not candidates for fetal intervention and were treated with standard prenatal betamethasone to increase lung maturity. Results: Three fetuses had CCAM and nonimmune hydrops fetalis diagnosed prenatally. After a course of prenatal steroids during the second trimester, all 3 patients had resolution of their hydrops and were delivered at term without respiratory distress. Conclusions: Nonimmune hydrops fetalis in fetuses with congenital cystic adenomatoid malformation is a harbinger for fetal demise. The resolution of hydrops in these patients after receiving steroid therapy is an interesting and compelling observation. Because the mechanism of this process is speculative, further studies are needed to elucidate the relationship between antenatal steroids and maturation of congenital cystic adenomatoid malformation.

Original languageEnglish (US)
Pages (from-to)508-510
Number of pages3
JournalJournal of Pediatric Surgery
Volume38
Issue number3
DOIs
StatePublished - Mar 1 2003
Externally publishedYes

Fingerprint

Congenital Cystic Adenomatoid Malformation of Lung
Hydrops Fetalis
Steroids
Fetus
Edema
Therapeutics
Betamethasone
Lung
Fetal Death
Second Pregnancy Trimester
Observation
Mortality

Keywords

  • Congenital cystic adenomatoid malformation
  • Steroids

ASJC Scopus subject areas

  • Surgery

Cite this

Resolution of hydrops fetalis in congenital cystic adenomatoid malformation after prenatal steroid therapy. / Tsao, KuoJen; Hawgood, Samuel; Vu, Lan; Hirose, Shinjiro; Sydorak, Roman; Albanese, Craig T.; Farmer, Diana L; Harrison, Michael R.; Lee, Hanmin.

In: Journal of Pediatric Surgery, Vol. 38, No. 3, 01.03.2003, p. 508-510.

Research output: Contribution to journalArticle

Tsao, KuoJen ; Hawgood, Samuel ; Vu, Lan ; Hirose, Shinjiro ; Sydorak, Roman ; Albanese, Craig T. ; Farmer, Diana L ; Harrison, Michael R. ; Lee, Hanmin. / Resolution of hydrops fetalis in congenital cystic adenomatoid malformation after prenatal steroid therapy. In: Journal of Pediatric Surgery. 2003 ; Vol. 38, No. 3. pp. 508-510.
@article{23fc79aa49534f698c54e25a9795e984,
title = "Resolution of hydrops fetalis in congenital cystic adenomatoid malformation after prenatal steroid therapy",
abstract = "Background/Purpose: Development of hydrops fetalis in fetuses with congenital cystic adenomatoid malformations (CCAM) is a significant risk factor for fetal or neonatal demise. In rare cases, resolution of CCAM has occurred, presumably owing to lesion maturation or involution. Steroid therapy, utilized for lung maturity, has been postulated to accelerate this process. The natural history of hydropic fetuses with CCAM after receiving steroid therapy is presented. Methods: The authors prospectively followed up with 3 patients who had antenatally diagnosed CCAM and nonimmune hydrops fetalis with predicted mortality. All patients declined or were not candidates for fetal intervention and were treated with standard prenatal betamethasone to increase lung maturity. Results: Three fetuses had CCAM and nonimmune hydrops fetalis diagnosed prenatally. After a course of prenatal steroids during the second trimester, all 3 patients had resolution of their hydrops and were delivered at term without respiratory distress. Conclusions: Nonimmune hydrops fetalis in fetuses with congenital cystic adenomatoid malformation is a harbinger for fetal demise. The resolution of hydrops in these patients after receiving steroid therapy is an interesting and compelling observation. Because the mechanism of this process is speculative, further studies are needed to elucidate the relationship between antenatal steroids and maturation of congenital cystic adenomatoid malformation.",
keywords = "Congenital cystic adenomatoid malformation, Steroids",
author = "KuoJen Tsao and Samuel Hawgood and Lan Vu and Shinjiro Hirose and Roman Sydorak and Albanese, {Craig T.} and Farmer, {Diana L} and Harrison, {Michael R.} and Hanmin Lee",
year = "2003",
month = "3",
day = "1",
doi = "10.1053/jpsu.2003.50089",
language = "English (US)",
volume = "38",
pages = "508--510",
journal = "Journal of Pediatric Surgery",
issn = "0022-3468",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Resolution of hydrops fetalis in congenital cystic adenomatoid malformation after prenatal steroid therapy

AU - Tsao, KuoJen

AU - Hawgood, Samuel

AU - Vu, Lan

AU - Hirose, Shinjiro

AU - Sydorak, Roman

AU - Albanese, Craig T.

AU - Farmer, Diana L

AU - Harrison, Michael R.

AU - Lee, Hanmin

PY - 2003/3/1

Y1 - 2003/3/1

N2 - Background/Purpose: Development of hydrops fetalis in fetuses with congenital cystic adenomatoid malformations (CCAM) is a significant risk factor for fetal or neonatal demise. In rare cases, resolution of CCAM has occurred, presumably owing to lesion maturation or involution. Steroid therapy, utilized for lung maturity, has been postulated to accelerate this process. The natural history of hydropic fetuses with CCAM after receiving steroid therapy is presented. Methods: The authors prospectively followed up with 3 patients who had antenatally diagnosed CCAM and nonimmune hydrops fetalis with predicted mortality. All patients declined or were not candidates for fetal intervention and were treated with standard prenatal betamethasone to increase lung maturity. Results: Three fetuses had CCAM and nonimmune hydrops fetalis diagnosed prenatally. After a course of prenatal steroids during the second trimester, all 3 patients had resolution of their hydrops and were delivered at term without respiratory distress. Conclusions: Nonimmune hydrops fetalis in fetuses with congenital cystic adenomatoid malformation is a harbinger for fetal demise. The resolution of hydrops in these patients after receiving steroid therapy is an interesting and compelling observation. Because the mechanism of this process is speculative, further studies are needed to elucidate the relationship between antenatal steroids and maturation of congenital cystic adenomatoid malformation.

AB - Background/Purpose: Development of hydrops fetalis in fetuses with congenital cystic adenomatoid malformations (CCAM) is a significant risk factor for fetal or neonatal demise. In rare cases, resolution of CCAM has occurred, presumably owing to lesion maturation or involution. Steroid therapy, utilized for lung maturity, has been postulated to accelerate this process. The natural history of hydropic fetuses with CCAM after receiving steroid therapy is presented. Methods: The authors prospectively followed up with 3 patients who had antenatally diagnosed CCAM and nonimmune hydrops fetalis with predicted mortality. All patients declined or were not candidates for fetal intervention and were treated with standard prenatal betamethasone to increase lung maturity. Results: Three fetuses had CCAM and nonimmune hydrops fetalis diagnosed prenatally. After a course of prenatal steroids during the second trimester, all 3 patients had resolution of their hydrops and were delivered at term without respiratory distress. Conclusions: Nonimmune hydrops fetalis in fetuses with congenital cystic adenomatoid malformation is a harbinger for fetal demise. The resolution of hydrops in these patients after receiving steroid therapy is an interesting and compelling observation. Because the mechanism of this process is speculative, further studies are needed to elucidate the relationship between antenatal steroids and maturation of congenital cystic adenomatoid malformation.

KW - Congenital cystic adenomatoid malformation

KW - Steroids

UR - http://www.scopus.com/inward/record.url?scp=0037373052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037373052&partnerID=8YFLogxK

U2 - 10.1053/jpsu.2003.50089

DO - 10.1053/jpsu.2003.50089

M3 - Article

C2 - 12632377

AN - SCOPUS:0037373052

VL - 38

SP - 508

EP - 510

JO - Journal of Pediatric Surgery

JF - Journal of Pediatric Surgery

SN - 0022-3468

IS - 3

ER -